Benjamin L Palleiko, the CHIEF EXECUTIVE OFFICER of $KALV, sold 10,926 shares of the company on 05-22-2026 for an estimated $292,646. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.2% of their shares of this class of stock. Following this trade, they now own 479,989 shares of this class of $KALV stock.
$KALV Insider Trading Activity
$KALV insiders have traded $KALV stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:
- HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 0 purchases and 5 sales selling 214,631 shares for an estimated $3,691,147.
- BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 8 sales selling 52,211 shares for an estimated $1,026,924.
- PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 4 sales selling 11,888 shares for an estimated $227,006.
- NICOLE SWEENY (Chief Commercial Officer) has made 0 purchases and 3 sales selling 7,698 shares for an estimated $149,366.
- CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 3 sales selling 7,814 shares for an estimated $147,461.
- BRIAN PIEKOS (Chief Financial Officer) has made 0 purchases and 3 sales selling 5,118 shares for an estimated $105,031.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$KALV Hedge Fund Activity
We have seen 98 institutional investors add shares of $KALV stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 984,520 shares (-34.0%) from their portfolio in Q1 2026, for an estimated $19,818,387
- GREAT POINT PARTNERS LLC added 685,632 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,072,956
- SIO CAPITAL MANAGEMENT, LLC removed 683,819 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,043,676
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 665,012 shares (-56.8%) from their portfolio in Q1 2026, for an estimated $13,386,691
- DRIEHAUS CAPITAL MANAGEMENT LLC added 564,039 shares (+inf%) to their portfolio in Q1 2026, for an estimated $11,354,105
- SPRUCE STREET CAPITAL LP added 509,713 shares (+131.4%) to their portfolio in Q1 2026, for an estimated $10,260,522
- TANG CAPITAL MANAGEMENT LLC removed 468,268 shares (-9.3%) from their portfolio in Q4 2025, for an estimated $7,562,528
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$KALV Price Targets
Multiple analysts have issued price targets for $KALV recently. We have seen 5 analysts offer price targets for $KALV in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Andrew S. Fein from HC Wainwright & Co. set a target price of $27.0 on 05/01/2026
- Jonathan Wolleben from Citizens set a target price of $28.0 on 03/26/2026
- Paul Matteis from Stifel set a target price of $42.0 on 03/26/2026
- Serge Belanger from Needham set a target price of $36.0 on 03/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
